ARTICLE SUMMARY:
In this latest roundup: A CMS proposed that could map out an accelerated coverage route for new devices is coming soon. And FDA rolls out its policy on ClinicalTrials.gov enforcement, proposes to reclassify an orthopedics device, and more.
A long-awaited CMS proposal that could afford a quick path to Medicare coverage for new devices is expected out any day. That and FDA’s plans for bone growth stimulators and ClinicalTrials.gov enforcement in this latest edition of Pathways’ Picks.
